Answer:
Yes, “The role of ablation in the management of certain primary and secondary tumours in the liver, lung, kidney and soft tissues has been approved by the National Institute of Health and Clinical Excellence (NICE).” – Dr Rowland Illing, Consultant Interventional Oncologist See - Latest Cancer Therapies